These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2956847)

  • 1. Insights into coronary angioplasty-induced restenosis from examination of atherogenesis.
    Wolinsky H
    Am J Cardiol; 1987 Jul; 60(3):65B-67B. PubMed ID: 2956847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of angioplasty and its relation to restenosis.
    Faxon DP; Sanborn TA; Haudenschild CC
    Am J Cardiol; 1987 Jul; 60(3):5B-9B. PubMed ID: 2956843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty.
    Macdonald RG; Panush RS; Pepine CJ
    Am J Cardiol; 1987 Jul; 60(3):56B-60B. PubMed ID: 2956845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses.
    Haudenschild CC
    Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty.
    Adams PC; Badimon JJ; Badimon L; Chesebro JH; Fuster V
    Cardiovasc Clin; 1987; 18(1):49-71. PubMed ID: 2955894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery restenosis following transluminal coronary angioplasty.
    Bruneval P; Guermonprez JL; Perrier P; Carpentier A; Camilleri JP
    Arch Pathol Lab Med; 1986 Dec; 110(12):1186-7. PubMed ID: 2946273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.
    Liu MW; Roubin GS; King SB
    Circulation; 1989 Jun; 79(6):1374-87. PubMed ID: 2524293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early phenomena of restenosis following percutaneous transluminal coronary angioplasty.
    Ueda M; Becker AE; Fujimoto T; Tsukada T
    Eur Heart J; 1991 Aug; 12(8):937-45. PubMed ID: 1915432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Restenosis after coronary angioplasty: its pathogenesis and prevention].
    Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty.
    Waller BF; Pinkerton CA; Orr CM; Slack JD; VanTassel JW; Peters T
    Circulation; 1991 Feb; 83(2 Suppl):I28-41. PubMed ID: 1991400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology: insight into the causes and prevention of restenosis after arterial intervention.
    Wilcox JN
    Am J Cardiol; 1993 Oct; 72(13):88E-95E. PubMed ID: 8213576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vessel wall reaction in restenosis.
    Schwartz RS
    Semin Interv Cardiol; 1997 Jun; 2(2):83-8. PubMed ID: 9546996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty.
    Berk BC; Gordon JB; Alexander RW
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):111B-117B. PubMed ID: 2016469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vascular stem cells in atherogenesis and post-angioplasty restenosis.
    Qian H; Yang Y; Li J; Huang J; Dou K; Yang G
    Ageing Res Rev; 2007 Aug; 6(2):109-27. PubMed ID: 17324640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
    Harker LA
    Am J Cardiol; 1987 Jul; 60(3):20B-28B. PubMed ID: 2956836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis after coronary angioplasty.
    Hamon M; Bauters C; McFadden EP; Wernert N; Lablanche JM; Dupuis B; Bertrand ME
    Eur Heart J; 1995 Aug; 16 Suppl I():33-48. PubMed ID: 8829956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediators of restenosis.
    Kagan SA; Myers SI
    Surg Clin North Am; 1998 Jun; 78(3):481-500. PubMed ID: 9673658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
    Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
    Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.